Genetic and epigenetic alterations in breast cancer: what are the perspectives for clinical practice? - Wikidata - awgldk - TriplyDB

Genetic and epigenetic alterations in breast cancer: what are the perspectives for clinical practice?

Genetic and epigenetic alterations in breast cancer: what are the perspectives for clinical practice?

http://www.wikidata.org/entity/Q37025333

about

Identification of four potential epigenetic modulators from the NCI structural diversity library using a cell-based assay.Decreased expression of the CHD5 gene and its clinicopathological significance in breast cancer: Correlation with aberrant DNA methylation.Unique epigenetic gene profiles define human breast cancers with poor prognosis.Deregulations in the cyclin-dependent kinase-9-related pathway in cancer: implications for drug discovery and development.The role of the dysfunctional akt-related pathway in cancer: establishment and maintenance of a malignant cell phenotype, resistance to therapy, and future strategies for drug development.Development of safer gene delivery systems to minimize the risk of insertional mutagenesis-related malignancies: a critical issue for the field of gene therapy.Targeting the Epigenome as a Novel Therapeutic Approach for Breast Cancer.Interplay between membrane lipid peroxidation, transglutaminase activity, and cyclooxygenase 2 expression in the tissue adjoining to breast cancer.

P2860

Q33793209-836BE95B-FE78-4B64-94AF-249BCDAA7C62 Q37407277-4354A2D6-9382-45AD-A41C-8F85D3034C20 Q37699138-B3AF8360-0309-4ECB-B531-A92D59401357 Q38120534-07BD96B3-7110-4167-8DFB-BD2ED37B15A7 Q38175044-A7B4CDAB-5FF0-415B-8248-2B28C5AAF09F Q41948139-D8FE52D9-63DB-468C-836A-E75796239137 Q49544302-19A4B9EF-2333-4701-A629-EB40C511A66F Q51174871-6896F0C7-DC46-40F7-B6A4-D7903E6FF446

P2860

Genetic and epigenetic alterations in breast cancer: what are the perspectives for clinical practice?

http://www.wikidata.org/entity/Q37025333

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 23 October 2007

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Genetic and epigenetic alterat ...... ectives for clinical practice?

@en

Genetic and epigenetic alterat ...... ectives for clinical practice?

@nl

type

label

Genetic and epigenetic alterat ...... ectives for clinical practice?

@en

Genetic and epigenetic alterat ...... ectives for clinical practice?

@nl

prefLabel

Genetic and epigenetic alterat ...... ectives for clinical practice?

@en

Genetic and epigenetic alterat ...... ectives for clinical practice?

@nl

P1433

Q37025333-3011C6DC-5060-4BDC-BA1C-2B22532B74E0

P1476

Q37025333-E62ECB19-04B2-4084-8277-5AB161D8CA7F

P2093

Q37025333-8AFF9D77-0278-482C-8316-6907846D2141

Q37025333-8FB3CC27-E3C7-4AE6-88CB-AB046745E30A

Q37025333-A2EF2315-CAB3-45A3-B4A6-7F13474A57C6

P2860

Q37025333-01EA1CA1-3D55-434C-A7F7-4BBFA499D708

Q37025333-037564B3-F078-4611-B03A-B5AD4D8109FA

Q37025333-05785E88-FC8B-400C-949E-AA4E311D6336

Q37025333-09634321-F1F1-4545-91BD-D2DBF527EC56

Q37025333-0A1DC407-14F7-424E-848A-97216DDD3CE6

Q37025333-0B0B8270-1AAB-4562-BD3C-311EEB5285AC

Q37025333-0C85EF5E-E355-4D3C-B38E-D93BAE676000

Q37025333-0D294EF8-A614-4C90-A7DD-F174907B042E

Q37025333-1333E716-3373-463A-8B6C-FD514123422D

Q37025333-17267634-3EBE-476D-9DDA-857607AE03C4

P304

Q37025333-A0B1C84C-BA2B-42C9-A6D1-9EAA4030E10B

P31

Q37025333-DEE38152-C26F-4990-886F-8581AF7AA3C2

P356

Q37025333-42BBD1B4-7CDA-4B36-BE39-2E63D9A17D73

P433

Q37025333-07F773E1-BBA9-469E-ABBE-6A9E4A2A91AD

P478

Q37025333-8060065E-8E28-4445-9A6C-3433FCE0F810

P50

Q37025333-2E664FFE-3703-440D-AA8D-EBB10A9A96CE

P577

Q37025333-15CCD79E-4FA8-4873-815C-55A34E063135

P5875

Q37025333-BD21130F-6AB1-4C7A-8801-B39FCFE69E82

P698

Q37025333-FA87760B-44D7-4087-8FCF-87942165CBF7

P932

Q37025333-52321E00-E89A-471F-91CF-E9044B2178AB

P356

J.BIOCEL.2007.10.018

P1433

International Journal of Biochemistry & Cell Biology

P1476

Genetic and epigenetic alterat ...... ectives for clinical practice?

@en

P2093

Alfredo Fucito

http://www.w3.org/2001/XMLSchema#string

Chiara Lucchetti

http://www.w3.org/2001/XMLSchema#string

Gaetano Romano

http://www.w3.org/2001/XMLSchema#string

P2860

Histone demethylation mediated by the nuclear amine oxidase homolog LSD1

Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer

A silencing pathway to induce H3-K9 and H4-K20 trimethylation at constitutive heterochromatin

EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells

Histone methyltransferase activity associated with a human multiprotein complex containing the Enhancer of Zeste protein

A phase I study of hydralazine to demethylate and reactivate the expression of tumor suppressor genes

Glioma stem cells promote radioresistance by preferential activation of the DNA damage response

The fundamental role of epigenetic events in cancer

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

pRb2/p130-E2F4/5-HDAC1-SUV39H1-p300 and pRb2/p130-E2F4/5-HDAC1-SUV39H1-DNMT1 multimolecular complexes mediate the transcription of estrogen receptor-alpha in breast cancer

P304

565-575

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BIOCEL.2007.10.018

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

40

http://www.w3.org/2001/XMLSchema#string

P50

Antonio Giordano

P577

2007-10-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5785773

http://www.w3.org/2001/XMLSchema#string

P698

18061512

http://www.w3.org/2001/XMLSchema#string

P932

2729585

http://www.w3.org/2001/XMLSchema#string